Other

Drugmaker paying $33M over recalled nonprescription meds

Johnson & Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold numerous nonprescription medicines that didn't meet federal quality requirements for a couple of years.

13 hours ago
popularity0 comments 0